Absci Corporation
ABSI • NASDAQ
Absci Corporation is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sean McClain, with a market cap of $425.4M.
CEOSean McClain
Next Earnings
Upcoming earnings announcement for Absci Corporation
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.20
Revenue Estimate
$1.7M
Earnings History
Past 12 earnings reports for Absci Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 24, 2026 | Q4 2025 | -$0.20Est: -$0.17 | -17.6% | $650.0KEst: $2.3M | -71.6% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.20Est: -$0.20 | 0.0% | $378.0KEst: $1.7M | -77.6% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.24Est: -$0.20 | -20.0% | $593.0KEst: $1.7M | -65.9% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.21Est: -$0.22 | +4.5% | $1.2MEst: $1.1M | +12.1% | 10-Q |
| Mar 18, 2025 | Q4 2024 | -$0.25Est: -$0.23 | -8.7% | $665.0KEst: $1.8M | -62.4% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.24Est: -$0.21 | -14.3% | $1.7MEst: $1.8M | -2.8% | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.22Est: -$0.19 | -15.8% | $1.3MEst: $1.9M | -33.5% | 10-Q |
| May 14, 2024 | Q1 2024 | -$0.22Est: -$0.21 | -4.8% | $898.0KEst: $2.4M | -62.9% | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.25Est: -$0.24 | -4.2% | $338.0KEst: $1.0M | -67.2% | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.24Est: -$0.23 | -4.3% | $744.0KEst: $3.0M | -75.3% | — |
| Aug 14, 2023 | Q2 2023 | -$0.22Est: -$0.24 | +8.3% | $3.4MEst: $2.4M | +38.0% | 10-Q |
| May 15, 2023 | Q1 2023 | -$0.26Est: -$0.24 | -8.3% | $1.3MEst: $2.3M | -43.6% | — |